Sartorius Stedim Biotech SA 2012 IR
The report highlights Sartorius Stedim Biotech Group's strong performance in fiscal year 2012, achieving double-digit growth with sales revenue increasing by 14% to ’544 million. Operationally, the company expanded its product portfolio by adding cell culture media through a cooperation agreement with Lonza and completed major infrastructure expansions in Puerto Rico and Germany. The Group also enhanced its sustainability reporting in compliance with French Grenelle II regulations, introducing new environmental and personnel indicators. Key achievements include receiving LEED Platinum certification for its expanded plant in Yauco and reducing carbon dioxide emissions at its Goettingen site.
Company: Sartorius Stedim Biotech SA
Sector: Manufacturing
Country: France
Year: 2012
Type: IR
Pages: 185
Back to company
Sartorius Stedim Biotech SA
Reference Document
The report highlights Sartorius Stedim Biotech Group's strong performance in fiscal year 2012, achieving double-digit growth with sales revenue increasing by 14% to ’544 million. Operationally, the company expanded its product portfolio by adding cell culture media through a cooperation agreement with Lonza and completed major infrastructure expansions in Puerto Rico and Germany. The Group also enhanced its sustainability reporting in compliance with French Grenelle II regulations, introducing new environmental and personnel indicators. Key achievements include receiving LEED Platinum certification for its expanded plant in Yauco and reducing carbon dioxide emissions at its Goettingen site.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2012
Reporting Period
Jan 1, 2012 - Dec 31, 2012
Fiscal Year
2012
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Energy Consumption
Water Consumption
Total Waste
Employees